Literature DB >> 31062121

Robotic radical nephroureterectomy and segmental ureterectomy for upper tract urothelial carcinoma: a multi-institutional experience.

Riccardo Campi1,2, Juliette Cotte3, Francesco Sessa1, Thomas Seisen3, Riccardo Tellini1, Daniele Amparore4, Nicola Mormile1, Aurélien Gobert3, Andrea Mari1,2, Francesco Porpiglia4, Sergio Serni1,2, Andrea Minervini1,2, Morgan Rouprêt5.   

Abstract

PURPOSE: To report a multi-institutional experience on robotic radical nephroureterectomy (RNU) and segmental ureterectomy (SU) for upper tract urothelial carcinoma (UTUC).
METHODS: Data were prospectively collected from patients with non-metastatic UTUC undergoing robotic SU or RNU at three referral centers between 2015 and 2018. Transperitoneal, single-docking robotic RNU followed established principles. Bladder cuff excision (BCE) was performed with robotic or open approach. Techniques for SU included: ureteral resection and primary uretero-ureterostomy; partial pyelectomy and modified pyeloplasty; ureteral resection with BCE and direct- or psoas hitch-ureteroneocystostomy. We retrospectively evaluated the technical feasibility, and peri-operative and oncologic outcomes after robotic RNU/SU.
RESULTS: 81 patients were included. No case required conversion to open surgery. Early major (Clavien-Dindo grade > 2) complications were reported in six (7.4%) patients (two after SU, four after RNU). Three patients experienced late major complications (one after SU, two after RNU). Median ΔeGFR at 3 months was - 1 ml/min/1.73 m2 after SU and - 15 ml/min/1.73 m2 after RNU. Positive surgical margins were recorded in five patients (one after SU, four after RNU). Median follow-up was 21 months and 22 months in the SU and RNU groups, respectively. Three (20%) patients had ipsilateral upper tract recurrence after SU, while five (7.5%) developed metastases after RNU. No case of port-site metastases or peritoneal carcinomatosis was reported. At last follow-up, 67 (82.7%) patients were alive without evidence of disease.
CONCLUSION: Robotic SU and RNU are technically feasible and achieved promising peri-operative and oncologic outcomes in selected patients with non-metastatic UTUC.

Entities:  

Keywords:  Radical nephroureterectomy; Renal pelvis; Robotics; Segmental ureterectomy; Ureter; Urothelial carcinoma

Mesh:

Year:  2019        PMID: 31062121     DOI: 10.1007/s00345-019-02790-y

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  7 in total

1.  A patient with synchronous bilateral low-grade upper tract urothelial carcinoma who underwent nephroureterectomy and total ureterectomy with ileal ureteric replacement.

Authors:  Yoshinori Matsuda; Takamitsu Inoue; Atsushi Maeno; Atsushi Koizumi; Ryohei Yamamoto; Taketoshi Nara; Sohei Kanda; Kazuyuki Numakura; Mitsuru Saito; Shintaro Narita; Shigeru Satoh; Tomonori Habuchi
Journal:  Int Cancer Conf J       Date:  2020-03-03

2.  Investigation of a novel brachytherapy ureteral stent: trial studies on normal beagle dogs.

Authors:  Dechao Jiao; Yuan Yao; Kaihao Xu; Qinyu Lei; Zongming Li; Xinwei Han; Jianzhuang Ren
Journal:  J Cancer Res Clin Oncol       Date:  2021-01-25       Impact factor: 4.553

3.  Survival and Long-term Effects of Kidney-sparing Surgery Versus Radical Nephroureterectomy on Kidney Function in Patients with Upper Urinary Tract Urothelial Carcinoma.

Authors:  Nora Hendriks; Joyce Baard; Harrie P Beerlage; Barbara M A Schout; Klara S G Doherty; Rob C M Pelger; Guido M Kamphuis
Journal:  Eur Urol Open Sci       Date:  2022-05-02

4.  Role of the Laparoscopic Approach for Complex Urologic Surgery in the Era of Robotics.

Authors:  Iulia Andras; Angelo Territo; Teodora Telecan; Paul Medan; Ion Perciuleac; Alexandru Berindean; Dan V Stanca; Maximilian Buzoianu; Ioan Coman; Nicolae Crisan
Journal:  J Clin Med       Date:  2021-04-21       Impact factor: 4.241

Review 5.  Perioperative complications and adverse sequelae of radical nephroureterectomy.

Authors:  Alison Levy; David Canes
Journal:  Transl Androl Urol       Date:  2020-08

6.  Evaluation of Pre-operative Biopsy, Surgical Procedures and Oncologic Outcomes in Upper Tract Urothelial Carcinoma (UTUC).

Authors:  Florestan J Koll; Eva Meisenzahl; Bernhard Haller; Philipp Maisch; Florian Kirchhoff; Thomas Horn; Jürgen E Gschwend; Sebastian C Schmid
Journal:  Front Surg       Date:  2021-11-25

Review 7.  Nephron-sparing approaches in the management of upper tract urothelial carcinoma: indications and clinical outcomes.

Authors:  Young Hwii Ko
Journal:  Transl Cancer Res       Date:  2020-10       Impact factor: 1.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.